Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Esophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06078657
What this trial is testing

IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)PD-1 Inhibitors
The First Affiliated Hospital of Zhengzhou University 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05176002
What this trial is testing

Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.

Who this might be right for
Esophageal NeoplasmImmunotherapyRadiotherapy
Fujian Medical University Union Hospital 25
Not applicableLooking for participantsNCT07354295
What this trial is testing

Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer （Radiogenomics-Esophagus）

Who this might be right for
Esophageal Cancer
Shu Peng 1,500
Early research (Phase 1)Ended earlyNCT04458259
What this trial is testing

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Who this might be right for
Neoplasm Metastasis
Pfizer 88
Not applicableUnknownNCT03962179
What this trial is testing

Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent)

Who this might be right for
Perforation EsophagusEsophageal CancerEsophageal Achalasia+1 more
University Hospital of Cologne 20
Testing effectiveness (Phase 2)Study completedNCT00220129
What this trial is testing

Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus

Who this might be right for
Oesophageal Carcinoma
Royal Marsden NHS Foundation Trust 16
Not applicableStudy completedNCT04217239
What this trial is testing

A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy

Who this might be right for
Esophageal Cancer
The Second Hospital of Shandong University 272
Testing effectiveness (Phase 2)Ended earlyNCT00268437
What this trial is testing

Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 27
Not applicableStudy completedNCT06219031
What this trial is testing

The Tumor Microenvironment Affecting the Efficacy of Immunotherapy for Esophageal Cancer

Who this might be right for
Esophageal Cancer
Renmin Hospital of Wuhan University 22
Testing effectiveness (Phase 2)UnknownNCT02938195
What this trial is testing

Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer

Who this might be right for
Esophageal CancerChemoradiationSurgery
Shanghai Chest Hospital 50
Post-approval studies (Phase 4)UnknownNCT01038154
What this trial is testing

Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal Cancer

Who this might be right for
Esophageal CancerStomach Cancer
Hospital Donostia 146
Testing effectiveness (Phase 2)UnknownNCT04006041
What this trial is testing

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma by AJCC V8 StageResectable Esophageal Cancer
Jianhua Fu 44
Not applicableLooking for participantsNCT06596954
What this trial is testing

Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Cancer
Ruijin Hospital 212
Testing effectiveness (Phase 2)Ended earlyNCT03168594
What this trial is testing

Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine Carcinoma
Peking University 66
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Not applicableStudy completedNCT03216694
What this trial is testing

The Association Between Preoperative CPEX and Postoperative Morbidity Following Oesophagectomy

Who this might be right for
Oesophageal Cancer
University of East Anglia 254
Not applicableStudy completedNCT02199002
What this trial is testing

Acid Pocket: Position and Aspiration

Who this might be right for
GERD - PPI RespondersGERD - PPI Non-respondersBarrett Esophagus+1 more
KU Leuven 70
Testing effectiveness (Phase 2)Ended earlyNCT01830270
What this trial is testing

Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer

Who this might be right for
Stomach NeoplasmsOesophageal Junction CancerLower Oesophagus Cancer
Centre Hospitalier Universitaire de Besancon 30
Testing effectiveness (Phase 2)Study completedNCT00054457
What this trial is testing

Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction

Who this might be right for
Esophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 46
Testing effectiveness (Phase 2)Ended earlyNCT00130936
What this trial is testing

Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates

Who this might be right for
Gastric CancerEsophageal CancerTumors
AHS Cancer Control Alberta 50
Next Page